It remains to be demonstrated how inhibitors and analogues of key molecules of the S1P signaling pathway will affect immune cells in breast cancer and whether the combination of chemotherapy with such inhibitors may lead to a durable therapeutic response. Here, MBTPS1 is linked to breast cancer.